A review on the evolution of PD-1/PD-L1 immunotherapy for bladder cancer: The future is now
Bellmunt, Joaquin, Powles, Thomas, Vogelzang, Nicholas J
Published in Cancer treatment reviews (01.03.2017)
Published in Cancer treatment reviews (01.03.2017)
Get full text
Journal Article
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
Sweeney, Christopher J, Chen, Yu-Hui, Carducci, Michael, Liu, Glenn, Jarrard, David F, Eisenberger, Mario, Wong, Yu-Ning, Hahn, Noah, Kohli, Manish, Cooney, Matthew M, Dreicer, Robert, Vogelzang, Nicholas J, Picus, Joel, Shevrin, Daniel, Hussain, Maha, Garcia, Jorge A, DiPaola, Robert S
Published in The New England journal of medicine (20.08.2015)
Published in The New England journal of medicine (20.08.2015)
Get full text
Journal Article
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial
Kyriakopoulos, Christos E, Chen, Yu-Hui, Carducci, Michael A, Liu, Glenn, Jarrard, David F, Hahn, Noah M, Shevrin, Daniel H, Dreicer, Robert, Hussain, Maha, Eisenberger, Mario, Kohli, Manish, Plimack, Elizabeth R, Vogelzang, Nicholas J, Picus, Joel, Cooney, Matthew M, Garcia, Jorge A, DiPaola, Robert S, Sweeney, Christopher J
Published in Journal of clinical oncology (10.04.2018)
Published in Journal of clinical oncology (10.04.2018)
Get full text
Journal Article
Non-BRCA DNA Damage Repair Gene Alterations and Response to the PARP Inhibitor Rucaparib in Metastatic Castration-Resistant Prostate Cancer: Analysis From the Phase II TRITON2 Study
Abida, Wassim, Campbell, David, Patnaik, Akash, Shapiro, Jeremy D, Sautois, Brieuc, Vogelzang, Nicholas J, Voog, Eric G, Bryce, Alan H, McDermott, Ray, Ricci, Francesco, Rowe, Julie, Zhang, Jingsong, Piulats, Josep Maria, Fizazi, Karim, Merseburger, Axel S, Higano, Celestia S, Krieger, Laurence E, Ryan, Charles J, Feng, Felix Y, Simmons, Andrew D, Loehr, Andrea, Despain, Darrin, Dowson, Melanie, Green, Foad, Watkins, Simon P, Golsorkhi, Tony, Chowdhury, Simon
Published in Clinical cancer research (01.06.2020)
Published in Clinical cancer research (01.06.2020)
Get full text
Journal Article
Lenvatinib plus pembrolizumab in patients with either treatment-naive or previously treated metastatic renal cell carcinoma (Study 111/KEYNOTE-146): a phase 1b/2 study
Lee, Chung-Han, Shah, Amishi Yogesh, Rasco, Drew, Rao, Arpit, Taylor, Matthew H, Di Simone, Christopher, Hsieh, James J, Pinto, Alvaro, Shaffer, David R, Girones Sarrio, Regina, Cohn, Allen Lee, Vogelzang, Nicholas J, Bilen, Mehmet Asim, Gunnestad Ribe, Sara, Goksel, Musaberk, Tennøe, Øyvind Krohn, Richards, Donald, Sweis, Randy F, Courtright, Jay, Heinrich, Daniel, Jain, Sharad, Wu, Jane, Schmidt, Emmett V, Perini, Rodolfo F, Kubiak, Peter, Okpara, Chinyere E, Smith, Alan D, Motzer, Robert J
Published in The lancet oncology (01.07.2021)
Published in The lancet oncology (01.07.2021)
Get full text
Journal Article
Axitinib versus sorafenib as first-line therapy in patients with metastatic renal-cell carcinoma: a randomised open-label phase 3 trial
Hutson, Thomas E, Prof, Lesovoy, Vladimir, Prof, Al-Shukri, Salman, Prof, Stus, Viktor P, Prof, Lipatov, Oleg N, Prof, Bair, Angel H, PhD, Rosbrook, Brad, MS, Chen, Connie, PharmD, Kim, Sinil, MD, Vogelzang, Nicholas J, Prof
Published in The lancet oncology (01.12.2013)
Published in The lancet oncology (01.12.2013)
Get full text
Journal Article
Randomized, Double-Blind, Placebo-Controlled Phase III Trial Comparing Docetaxel and Prednisone With or Without Bevacizumab in Men With Metastatic Castration-Resistant Prostate Cancer: CALGB 90401
KEVIN KELLY, William, HALABI, Susan, VOGELZANG, Nicholas J, SMALL, Eric J, CARDUCCI, Michael, GEORGE, Daniel, MAHONEY, John F, STADLER, Walter M, MORRIS, Michael, KANTOFF, Philip, PAUL MONK, J, KAPLAN, Ellen
Published in Journal of clinical oncology (01.05.2012)
Published in Journal of clinical oncology (01.05.2012)
Get full text
Journal Article
Efficacy and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and symptomatic bone metastases, with or without previous docetaxel use: a prespecified subgroup analysis from the randomised, double-blind, phase 3 ALSYMPCA trial
Hoskin, Peter, Prof, Sartor, Oliver, Prof, O'Sullivan, Joe M, Prof, Johannessen, Dag Clement, MD, Helle, Svein I, MD, Logue, John, FRCR, Bottomley, David, FRCR, Nilsson, Sten, Prof, Vogelzang, Nicholas J, Prof, Fang, Fang, PhD, Wahba, Mona, MD, Aksnes, Anne-Kirsti, PhD, Parker, Christopher, MD
Published in The lancet oncology (01.11.2014)
Published in The lancet oncology (01.11.2014)
Get full text
Journal Article
Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study
Fizazi, Karim, Prof Dr, Scher, Howard I, Prof, Molina, Arturo, MD, Logothetis, Christopher J, Prof, Chi, Kim N, MD, Jones, Robert J, PhD, Staffurth, John N, MD, North, Scott, MD, Vogelzang, Nicholas J, MD, Saad, Fred, Prof, Mainwaring, Paul, MD, Harland, Stephen, MD, Goodman, Oscar B, MD, Sternberg, Cora N, MD, Li, Jin Hui, PhD, Kheoh, Thian, PhD, Haqq, Christopher M, MD, de Bono, Johann S, Prof
Published in The lancet oncology (01.10.2012)
Published in The lancet oncology (01.10.2012)
Get full text
Journal Article
Evolution of Circulating Tumor DNA Profile from First-line to Subsequent Therapy in Metastatic Renal Cell Carcinoma
Pal, Sumanta K, Sonpavde, Guru, Agarwal, Neeraj, Vogelzang, Nicholas J, Srinivas, Sandy, Haas, Naomi B, Signoretti, Sabina, McGregor, Bradley A, Jones, Jeremy, Lanman, Richard B, Banks, Kimberly C, Choueiri, Toni K
Published in European urology (01.10.2017)
Published in European urology (01.10.2017)
Get full text
Journal Article
Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial
Sartor, Oliver, Prof, Coleman, Robert, Prof, Nilsson, Sten, Prof, Heinrich, Daniel, MD, Helle, Svein I, MD, O'Sullivan, Joe M, Prof, Fosså, Sophie D, Prof, Chodacki, Aleš, MD, Wiechno, Paweł, MD, Logue, John, FRCR, Widmark, Anders, Prof, Johannessen, Dag Clement, MD, Hoskin, Peter, Prof, James, Nicholas D, Prof, Solberg, Arne, MD, Syndikus, Isabel, FRCR, Vogelzang, Nicholas J, Prof, O'Bryan-Tear, C Gillies, MRCP, Shan, Minghua, PhD, Bruland, Øyvind S, Prof, Parker, Christopher, MD
Published in The lancet oncology (01.06.2014)
Published in The lancet oncology (01.06.2014)
Get full text
Journal Article
Cabozantinib in Patients With Advanced Prostate Cancer: Results of a Phase II Randomized Discontinuation Trial
SMITH, David C, SMITH, Matthew R, VAISHAMPAYAN, Ulka N, HAAS, Naomi B, SPIRA, Alexander I, LARA, Primo N, LIN, Chia-Chi, SRINIVAS, Sandy, SELLA, Avishay, SCHÖFFSKI, Patrick, SCHEFFOLD, Christian, WEITZMAN, Aaron L, SWEENEY, Christopher, HUSSAIN, Maha, ELFIKY, Aymen A, LOGOTHETIS, Christopher, CORN, Paul G, VOGELZANG, Nicholas J, SMALL, Eric J, HARZSTARK, Andrea L, GORDON, Michael S
Published in Journal of clinical oncology (01.02.2013)
Published in Journal of clinical oncology (01.02.2013)
Get full text
Journal Article
Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: an open-label, randomised phase 3 trial
Motzer, Robert J, Dr Prof, Porta, Camillo, MD, Vogelzang, Nicholas J, Prof, Sternberg, Cora N, MD, Szczylik, Cezary, Prof, Zolnierek, Jakub, MD, Kollmannsberger, Christian, MD, Rha, Sun Young, MD, Bjarnason, Georg A, MD, Melichar, Bohuslav, Prof, De Giorgi, Ugo, MD, Grünwald, Viktor, Prof, Davis, Ian D, MBBS, Lee, Jae-Lyun, Prof, Esteban, Emilio, Prof, Urbanowitz, Gladys, MBA, Cai, Can, PhD, Squires, Matthew, PhD, Marker, Mahtab, PhD, Shi, Michael M, MD, Escudier, Bernard, Prof
Published in The lancet oncology (01.03.2014)
Published in The lancet oncology (01.03.2014)
Get full text
Journal Article
Health-Related Quality-of-Life Analysis From KEYNOTE-045: A Phase III Study of Pembrolizumab Versus Chemotherapy for Previously Treated Advanced Urothelial Cancer
Vaughn, David J, Bellmunt, Joaquim, Fradet, Yves, Lee, Jae Lyun, Fong, Lawrence, Vogelzang, Nicholas J, Climent, Miguel A, Petrylak, Daniel P, Choueiri, Toni K, Necchi, Andrea, Gerritsen, Winald, Gurney, Howard, Quinn, David I, Culine, Stephane, Sternberg, Cora N, Mai, Yabing, Li, Haojie, Perini, Rodolfo F, Bajorin, Dean F, de Wit, Ronald
Published in Journal of clinical oncology (01.06.2018)
Published in Journal of clinical oncology (01.06.2018)
Get full text
Journal Article
Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial
Falchook, Gerald S, Dr, Lewis, Karl D, MD, Infante, Jeffrey R, MD, Gordon, Michael S, MD, Vogelzang, Nicholas J, MD, DeMarini, Douglas J, PhD, Sun, Peng, PhD, Moy, Christopher, MS, Szabo, Stephen A, BA, Roadcap, Lori T, MS, Peddareddigari, Vijay GR, MD, Lebowitz, Peter F, MD, Le, Ngocdiep T, MD, Burris, Howard A, MD, Messersmith, Wells A, MD, O'Dwyer, Peter J, Prof, Kim, Kevin B, MD, Flaherty, Keith, MD, Bendell, Johanna C, MD, Gonzalez, Rene, Prof, Kurzrock, Razelle, Prof, Fecher, Leslie A, MD
Published in The lancet oncology (01.08.2012)
Published in The lancet oncology (01.08.2012)
Get full text
Journal Article
Characterization of metastatic urothelial carcinoma via comprehensive genomic profiling of circulating tumor DNA
Agarwal, Neeraj, Pal, Sumanta K., Hahn, Andrew W., Nussenzveig, Roberto H., Pond, Gregory R., Gupta, Sumati V., Wang, Jue, Bilen, Mehmet A., Naik, Gurudatta, Ghatalia, Pooja, Hoimes, Christopher J., Gopalakrishnan, Dharmesh, Barata, Pedro C., Drakaki, Alexandra, Faltas, Bishoy M., Kiedrowski, Lesli A., Lanman, Richard B., Nagy, Rebecca J., Vogelzang, Nicholas J., Boucher, Kenneth M., Vaishampayan, Ulka N., Sonpavde, Guru, Grivas, Petros
Published in Cancer (15.05.2018)
Published in Cancer (15.05.2018)
Get full text
Journal Article
Orteronel for Metastatic Hormone-Sensitive Prostate Cancer: A Multicenter, Randomized, Open-Label Phase III Trial (SWOG-1216)
Agarwal, Neeraj, Tangen, Catherine M, Hussain, Maha H A, Gupta, Shilpa, Plets, Melissa, Lara, Primo N, Harzstark, Andrea L, Twardowski, Przemyslaw W, Paller, Channing J, Zylla, Dylan, Zibelman, Matthew R, Levine, Ellis, Roth, Bruce J, Goldkorn, Amir, Vaena, Daniel A, Kohli, Manish, Crispino, Tony, Vogelzang, Nicholas J, Thompson, Jr, Ian M, Quinn, David I
Published in Journal of clinical oncology (01.10.2022)
Published in Journal of clinical oncology (01.10.2022)
Get full text
Journal Article
Multicenter Phase II Trial of Neoadjuvant Pemetrexed Plus Cisplatin Followed by Extrapleural Pneumonectomy and Radiation for Malignant Pleural Mesothelioma
KRUG, Lee M, PASS, Harvey I, OBASAJU, Coleman K, VOGELZANG, Nicholas J, RUSCH, Valerie W, KINDLER, Hedy L, SUGARBAKER, David J, ROSENZWEIG, Kenneth E, FLORES, Raja, FRIEDBERG, Joseph S, PISTERS, Katherine, MONBERG, Matthew
Published in Journal of clinical oncology (20.06.2009)
Published in Journal of clinical oncology (20.06.2009)
Get full text
Journal Article
Second-line systemic therapy and emerging drugs for metastatic transitional-cell carcinoma of the urothelium
Sonpavde, Guru, Dr, Sternberg, Cora N, MD, Rosenberg, Jonathan E, MD, Hahn, Noah M, MD, Galsky, Matthew D, MD, Vogelzang, Nicholas J, MD
Published in The lancet oncology (01.09.2010)
Published in The lancet oncology (01.09.2010)
Get full text
Journal Article
Docetaxel and prednisone with or without lenalidomide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer (MAINSAIL): a randomised, double-blind, placebo-controlled phase 3 trial
Petrylak, Daniel P, Prof, Vogelzang, Nicholas J, MD, Budnik, Nikolay, MD, Wiechno, Pawel Jan, MD, Sternberg, Cora N, Prof, Doner, Kevin, MD, Bellmunt, Joaquim, MD, Burke, John M, MD, de Olza, Maria Ochoa, MD, Choudhury, Ananya, PhD, Gschwend, Juergen E, Prof, Kopyltsov, Evgeny, MD, Flechon, Aude, MD, Van As, Nicolas, MD, Houede, Nadine, MD, Barton, Debora, MD, Fandi, Abderrahim, MD, Jungnelius, Ulf, MD, Li, Shaoyi, PhD, de Wit, Ronald, Prof, Fizazi, Karim, Prof
Published in The lancet oncology (01.04.2015)
Published in The lancet oncology (01.04.2015)
Get full text
Journal Article